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Abstract
Introduction: Blunt cerebrovascular injury (BCVI) is reported to occur in 1–2 % of blunt trauma patients. Clinical
and radiologic risk factors for BCVI have been described to help identify patients that require screening for these
injuries. However, recent studies have suggested that BCVI frequently occurs even in the absence of these risk factors.
The purpose of this study was to determine the incidence of BCVI in blunt trauma patients without risk factors and
whether these patients could be identified by a more liberal CTA screening protocol.
Methods: We conducted a retrospective cohort study of all blunt trauma patients seen between November 2010 and
May 2014. In May 2012, a clinical practice guideline for CTA screening for BCVI was implemented. The records of all
patients with BCVI were reviewed for the presence of risk factors for BCVI previously described in the literature.
Results: During the 43 month study period, 6,602 blunt trauma patients were evaluated, 2,374 prior to, and 4,228 after
implementation of the clinical practice guideline. Nineteen percent of all blunt trauma patients underwent CTA of the
neck after protocol implementation compared to only 1.5 % prior to protocol implementation (p = 0.001). As a result,
a 5-fold increase in the identification of BCVI was observed (p = 0.00003). Thirty-seven percent of patients with BCVI
identified with the enhanced CT screening protocol had none of the signs, symptoms, or risk factors usually associated
with these injuries.
Conclusions: Our findings demonstrate that reliance on clinical or radiologic risk factors alone as indications for screening
for BCVI is inadequate. We recommend routine CTA screening for BCVI in all patients who have sustained a mechanism
of injury sufficient to warrant either a CT of the cervical spine or a CTA of the chest.
Keywords: Blunt cerebrovascular injury, Carotid artery injury, Vertebral artery injury, Blunt trauma, Computer tomography,
CT angiography, CTA screening, Risk factors for BCVI, Signs/symptoms of BCVI, Stroke
Introduction
Although previously thought to be rare, blunt cerebrovas-
cular injury (BCVI) is now reported to occur in 1–2 % of
blunt trauma patients [1–3]. Early recognition of these in-
juries is crucial as the stroke rate in untreated patients with
BCVI is reported to be 20–60 % [4–9]. The majority of
these strokes occur following a latent, asymptomatic time
interval that can vary from hours to weeks [7, 10]. Initiation
of treatment with antiplatelet agents or anticoagulation
therapy during this asymptomatic period appears to reduce
the stroke rate to below 1 % [7, 11, 12].
Screening criteria and optimal imaging modalities to
identify patients with BCVI have been vigorously debated
over the last 15 years. The groups in Denver [13] and
Memphis [1] have identified an extensive list of clinical
and radiologic risk factors that warrant diagnostic imaging
and these studies have formed the basis of practice man-
agement guidelines published by the Western Trauma As-
sociation (WTA) in 2009 [13] and the Eastern Association
for the Surgery of Trauma (EAST) in 2010 [1]. Despite
these extensive lists of risk factors, several groups using
whole body multi-slice screening computed tomography
(CT) in multiple blunt trauma patients have recognized
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that as many as 30 % of patients with BCVI have none of
these risks factors [14]. In most of these patients, the first
sign of an undetected BCVI will be a completed stroke.
Because of our concern that using risk factors alone
might fail to identify a significant proportion of patients
with BCVI, our group initiated a protocol of routine CT
angiography (CTA) of the neck in any blunt trauma
patient who was already undergoing CT of the cervical
spine (C-spine) and/or CTA of the chest to screen for
these injuries. The purpose of this study was to determine
the incidence of BCVI in blunt trauma patients in the ab-
sence of any of the widely accepted risk factors currently
included in published practice management guidelines
and whether these patients could be identified by a more
liberal CTA screening.
Methods
St. Vincent Indianapolis Hospital is a 566 bed American
College of Surgeons-verified Level II trauma center lo-
cated in Indianapolis, Indiana. It serves as the receiving
trauma center for the 22 hospital St. Vincent Health sys-
tem within the state and has a fleet of five helicopters to
facilitate scene and inter-facility transports. In May of
2012, we initiated a clinical practice guideline for screen-
ing of blunt trauma patients for BCVI. All patients eval-
uated by the trauma service with a mechanism or injury
significant enough to warrant a CT of the C-spine and/
or a CTA of the chest underwent a CTA of the neck. Pa-
tients transferred from outside hospitals who had already
undergone CT of the C-spine and/or CTA of the chest
were not mandated to undergo routine screening for BCVI
due to the increased risk of a second dose of contrast
within 24 hours and the additional radiation exposure to
the neck. Similarly, emergency department physicians,
who evaluated many of the low mechanism/low risk pa-
tients initially, were not bound by the routine CTA of the
neck screening guideline. In these patients, CTA of the
neck was obtained at the discretion of the attending
trauma surgeon based on mechanism of injury, signs or
symptoms of BCVI, or the presence of known risk factors
for BCVI. In these cases, the study was performed imme-
diately. Prior to initiation of the protocol, CTA screening
for BCVI was based on the clinical judgment of the
trauma surgeon on call guided by the WTA and EAST
guidelines available at that time.
Imaging Protocol
All trauma studies were performed on one of two 64
slice CT scanners, the GE 750 HD or the GE LightSpeed
VCT (GE Healthcare, Waukesha, WI). The sequence of
the exams and the timing of the contrast injections were
optimized to minimize both the radiation and the con-
trast load delivered to the patient. All trauma patients
were positioned supine, head first, with their arms down
at their sides. CT scans of the head and face, when indi-
cated, were performed first without IV contrast. Patients
then underwent CTA of the neck and CT of the C-
spine, acquired during a single run, followed by CTA of
the chest (arterial phase) and CT of the abdomen and
pelvis (venous phase).
For the CTA of the neck, contrast injection was per-
formed using 60 mL of iohexol 350 at 4 mL per second,
followed by 20 mL of 0.9 % sodium chloride. Once con-
trast was seen entering the aortic arch, scanning was initi-
ated. Images were acquired at 0.625 mm slice thickness
and at 0.625 mm intervals (0.625 mm × 0.625 mm). Sagit-
tal images were reformatted at 2 mm × 2 mm and both
coronal and sagittal reformats were done in Maximal In-
tensity Projection (MIP) mode at 10 mm × 2.5 mm.
Images for the CT of the C-spine were obtained dur-
ing scanning for the CTA of the neck at 0.625 mm ×
0.625 mm. Reformats were then done manually with cor-
onal and sagittal images in bone window at 2 mm × 2 mm,
sagittal images in standard window at 2 mm × 2 mm and
angled axial reformats in bone and standard window at
2.5 mm × 2.5 mm.
For the CTA of the chest, 90 ml of iohexol 350 was used,
at an injection rate of 4 mL per second, followed by 20 mL
of 0.9 % sodium chloride. Arterial phase images were ac-
quired at 0.625 mm × 0.625 mm. Coronal and sagittal
reformats were done at 3 mm × 2 mm as well as coronal
and sagittal images in MIP mode at 5 mm × 3 mm.
CT of the abdomen and pelvis (venous phase) was
then automatically done 50 seconds after the start of the
CTA chest (arterial phase) and images were acquired at
1.25 mm × 0.75 mm with coronal and sagittal reformats
at 3 mm × 2 mm.
Treatment Protocol
All CTA studies of the neck done during the day were read
by an attending neuroradiologist. At night an experienced
in-house attending CT radiologist provided a preliminary
reading and any positive or equivocal studies were reviewed
the next morning by the attending neuroradiologist.
Patients with CTA findings suggestive of a BCVI were
seen by an attending neurosurgeon or vascular surgeon
and complex or equivocal studies were reviewed by an
interventional neuroradiologist. Additional imaging with
magnetic resonance angiography or repeat CTA was oc-
casionally performed to help differentiate injuries from
atherosclerotic disease. Treatment was initiated at the
discretion of the attending neurosurgeon or vascular sur-
geon. Patients with a CTA reading equivocal for BCVI
who were not felt to have injuries by the neurosurgeon or
vascular surgeon, and for whom no treatment was initi-
ated, were considered to be false positive studies and were
excluded.
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Patient Population
This retrospective cohort study was reviewed and ap-
proved by our organization’s Institutional Review Board.
The trauma registry was used to identify all blunt trauma
patients seen at our trauma center between November 1,
2010 and May 31, 2014. Our trauma registry is compliant
with the National Trauma Data Standard™ developed by
the American College of Surgeons Committee on Trauma
for inclusion in the National Trauma Data Bank™. Subjects
were divided into two groups based on whether they were
seen prior to (pre-protocol) or after (post-protocol) imple-
mentation of our routine CTA screening guideline for
BCVI which was initiated on May 1, 2012.
Data collection from the registry included age, sex,
mechanism of injury, Glasgow Coma Scale (GCS) score
[15] in the emergency department (ED), Abbreviated In-
jury Scale (AIS08) scores [16], Injury Severity Score (ISS)
[17], ICD-9 diagnosis codes, whether the patient under-
went CTA of the neck, and mortality prior to discharge.
All CTA of the neck reports were reviewed individually by
the primary author and all studies with findings suggestive
of BCVI were identified and the BCVI graded based on
the grading scale proposed by Biffl [18]. If a patient had
more than one CTA of the neck done, only the initial
study was included.
The medical records of all the patients with positive
studies were then reviewed for the presence of any of
the signs/symptoms or risk factors for BCVI outlined in
the new Denver Health Medical Center BCVI screening
guideline described by Burlew [11] (Table 1).
Statistical Analysis
Minitab 17 (State College, PA) was used for statistical ana-
lyses. Proportions and means with ranges were used to
summarize and compare patient demographics and the
prevalence of CTA screening and BCVI in pre- and post-
protocol groups. Pearson’s Chi-Square test for independ-
ence (χ2) and Student’s t test were used to assess differ-
ences by study group. Probability (p) values associated
with Fisher’s exact test are reported for 2 × 2 χ2 tables.
Yates correction for continuity was used if expected fre-
quencies were less than 5 in 2 × 2 χ2 tables. Binary Logis-
tic Regression was used to calculate the odds of BCVI
based on GCS and ISS (mild, moderate, and severe).
Results
During the 43 month study period, 6,602 patients who
had sustained blunt trauma were identified, 2,374 prior to
implementation of the routine CTA of the neck guideline
(pre-protocol) and 4,228 after implementation (post-
protocol). Patient demographics are provided in Table 2.
Of the 2,374 pre-protocol patients only 35 (1.5 %)
underwent CTA of the neck to evaluate for BCVI whereas
post-protocol 802 (19 %) were screened. Pre-protocol
there were 5 patients with BCVI identified for an inci-
dence of 0.2 % (Table 3). Post-protocol, 46 patients with
BCVI were identified for an overall incidence of 1.1 % in
all blunt trauma patients. However, in patients who under-
went CTA of the neck, the incidence was 5.7 % (46/802).
In all, 61 BCVIs were identified in 51 patients. There
were 30 common or internal carotid artery injuries and
31 vertebral artery injuries. Forty-two patients had one
BCVI, eight patients had 2 injuries and one patient had
3 injuries. The grading of these injuries is outlined in
Table 4.
Compared to non-BCVI patients, those with BCVI
had significantly greater mechanism of injury as indicated
by higher incidences of motor vehicle crashes (54.9 % vs
23.5 %, p = 0.001), motorcycle crashes (7.8 % vs 6.7 %, p =
0.016), pedestrians hit by car (13.7 % vs 4.3 %, p = 0.006),
and hangings/strangulations (2 % vs 0.1 %, p = 0.045) and
lower incidences of falls (21.6 % vs 52.4 %, p = 0.001).
BCVI patients were also a more severely injured group as
indicated by lower initial GCS scores (10.5 vs. 14.1, p =
0.001), higher ISS (23.2 vs. 8.4, p = 0.001), and higher
Table 1 New Denver Health Medical Center BCVI screening
criteria [11] and prevalence in post-protocol sample




Potential arterial hemorrhage from neck/nose/mouth 0
Cervical bruit in patients < 50 years old 0
Expanding cervical hematoma 1
Focal neurologic deficit (TIA, hemiparesis, vertebrobasilar
symptoms, Horner’s Syndrome)
1
Neurologic deficit inconsistent with head CT scan findings 0
Stroke on CT or MRI 4
Risk factors for BCVI
High-energy transfer mechanism associated with:
Displaced mid-face fracture (LeForte II or III) 1
Mandible fracture 3
Complex skull fracture/basilar skull fracture/occipital
condyle fracture
5
Closed head injury with diffuse axonal injury and GCS <6 7
Cervical subluxation or ligamentous injury, transverse
foramen fracture, any body fracture, any fracture C1–C3
18
Near hanging with anoxic brain injury 1
Clothesline type injury or seat belt abrasion with
significant swelling, pain, or altered mental status
0
Traumatic brain injury with thoracic injuries 7
Scalp degloving 3
Thoracic vascular injuries 3
Blunt cardiac rupture 0
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mortality (15.7 % vs. 3.1 %, p = 0.001) (Table 2). As shown
in Table 5, the likelihood of BCVI increased with decreas-
ing GCS score in the ED (p < 0.005) and increasing ISS (p
< 0.005). BCVI was 3.5 times more likely in patients with
moderate compared to mild GCS scores, and 7.9 times
more likely in patients with moderate compared to mild
ISS. These odds ratios were 2.6 and 4.8 respectively, as
scores increased from moderate to severe. Patients with
severe GCS scores and ISS were 9.4 and 38.3 times more
likely to have a BCVI than patients with mild scores.
Treatment of patients with BCVI was tailored to the
severity of the BCVI and the patient’s other injuries.
Thirty-five patients were treated with antiplatelet agents,
5 with systemic anticoagulation, and 4 with a combin-
ation of both. Seven patients received no treatment ei-
ther because they were too critical or because they died
before treatment could be initiated.
Of the 46 post-protocol patients with BCVI, 29 (63 %)
had at least one of the signs/symptoms or risk factors out-
lined in the new Denver Health Medical Center BCVI
screening guideline [11] (Table 1). Seventeen patients had
a single sign/symptom or risk factor, seven patients had 2,
two patients had 3, two patients had 4, and one patient
had 6 of the new Denver screening criteria. Cervical spine
injury (n = 18) was the most common risk factor, followed
by closed head injury with diffuse axonal injury and GCS
<6 (n = 7) and traumatic brain injury with thoracic injury
(n = 7). Finally, 17 (37 %) of the 46 post-protocol patients
with BCVI had no identifiable signs/symptoms or risk fac-
tors outlined in the new Denver screening guidelines.
Discussion
In 2012, we initiated a protocol of routine CTA of the neck
in any blunt trauma patient who was already undergoing
CT of the C-spine and/or CTA of the chest. The purpose
of this study was to determine whether identification of pa-
tients with BCVI was improved by this CT screening
protocol. Pre-protocol only 1.5 % of blunt trauma patients
underwent CTA of the neck to screen for BCVI, while
post-protocol 19 % were screened (p = 0.001), representing
a 13-fold increase in CTA screening (Fig. 1). As a result, a
5-fold increase in the incidence of BCVI was identified in
our patient population (5/2,374 patients, 0.2 % vs 46/4,228
patients, 1.1 %; p = 0.001). This apparent increase in the in-
cidence of BCVI is almost certainly the result of more in-
tensive screening rather than a true increase in incidence.
In all likelihood, these injuries were being missed prior to
the implementation of our BCVI screening guideline.
Thirty-seven percent of BCVI patients identified with
this enhanced CT screening protocol had none of the
clinical or radiologic risk factors listed in the expanded
Denver screening guidelines [11]. It therefore seems
clear that reliance on risk factors alone as the indication
for BCVI screening is likely to result in missed injuries
and potentially avoidable strokes.
Blunt cerebrovascular injuries are thought to result
from a combination of stretch induced disruption of the
layers of the vessel wall and direct injury caused by
Table 3 CTA screening and identification of BCVI by study group
Pre-Protocol Post-Protocol
n % n % p
All patients 2374 36.0 4228 64.0
CTA of the neck 35 1.5 802 19.0 0.001
BCVI 5 0.2 46 1.1 0.00003
Table 2 Demographic characteristics of study populations
Pre-Protocol Post-Protocol No BCVI BCVI
n % n % p n % n % p
Patients 2374 36.0 4228 64.0 6551 99.2 51 0.8
Male 1258 53.0 2330 55.1 0.100 3539 54.3 29 57.0 0.7787
Mortality 74 3.1 136 3.2 0.884 202 3.1 8 15.7 0.001
Mean Range Mean Range p Mean Range Mean Range p
Age (years) 54.6 15 to 100 54.6 14 to 100 0.974 54.6 14 to 100 54.0 16 to 89 0.800
GCS in ED 14.1 3 to 15 14.1 3 to 15 0.711 14.1 3 to 15 10.5 3 to 15 0.001
ISS 8.2 1 to 75 8.6 1 to 75 0.052 8.4 1 to 75 23.2 4 to 75 0.001
GCS = Glasgow Coma Scale; ISS = Injury Severity Score
Table 4 Grading of BCVIs [18]
Grade Definition n %
I Luminal irregularity or dissection with <25 %
luminal narrowing
34 55.7
II Dissection or intramural hematoma with ≥25 %
luminal narrowing
7 11.5
III Pseudoaneurysm 6 9.8
IV Occlusion 14 23.0
V Transection with free extravasation 0 0.0
Total 61 100.0
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fractures of the transverse foramina of the cervical verte-
brae [2]. Identification of these lesions and treatment
with anticoagulation or antiplatelet agents is recognized
to be crucial to prevent embolization or propagation of
thrombus into the distal cerebral vessels.
Until relatively recently, blunt cerebrovascular injury
was thought to be a rare entity. In 1990, Davis et al.
[19] reported on a series of 15,935 blunt trauma pa-
tients admitted over a 5 year period in San Diego
County and identified 14 patients with blunt carotid
injuries for a detected incidence of 0.08 %. Consistent
with the standard of care at that time, all injuries
were diagnosed by angiography and the majority (11/14,
79 %) only after symptoms or CT findings of completed
stroke. Over the next 20 years, however, several crucial
observations significantly altered the management and
prognosis of these lesions.
Firstly, anticoagulation was shown to improve neuro-
logic outcomes in patients with strokes related to BCVI
[2, 5, 6, 9, 11, 19, 20]. In addition, early anticoagulation
or antiplatelet therapy has been shown to decrease
stroke rate in asymptomatic patients with BCVI from as
high as 60 % to less than 1 % [7, 11, 12, 21]. Full anticoa-
gulation is frequently contraindicated in blunt trauma
patients due to associated injuries. A recent Cochrane
review [22], however, failed to demonstrate a difference
in efficacy between anticoagulation and aspirin and con-
cluded that aspirin was as effective as anticoagulation,
but with a lower risk of hemorrhage. This would support
early initiation of effective therapy in the form of aspirin,
even in high risk trauma patients.
Secondly, it has been widely recognized that the
vast majority of BCVIs are asymptomatic at the time
of presentation and that neurologic symptoms only
develop after some variable time interval. This latent,
asymptomatic period prior to development of stroke can
vary from minutes to years but most commonly lasts from
10 to 72 hours following injury [2, 4, 6–8, 11, 18, 23–26].
Although patients may occasionally present with symp-
toms of transient ischemic attack, in most the first symp-
tom will be a completed ischemic stroke. It is therefore
crucial to identify BCVI during this latent period and to
initiate treatment before irreversible neurologic injury
occurs.
Table 5 Prevalence and likelihood of BCVI based on GCS score and ISS





n % n %
GCS in ED
Mild 4655 99.4 27 0.6 Moderate vs. Mild 3.5 [1.2:10.2] 38.3 <0.005
Moderate 195 98.0 4 2.0 Severe vs. Moderate 2.6 [0.9:8.0]
Severe 295 94.9 16 5.1 Severe vs. Mild 9.4 [5.0:17.5]
ISS
Mild 4679 99.8 9 0.2 Moderate vs. Mild 7.9 [3.6:17.1] 88.1 <0.005
Moderate 1513 98.5 23 1.5 Severe vs. Moderate 4.8 [2.6:9.0]
Severe 258 93.1 19 6.9 Severe vs. Mild 38.3 [17.2:85.5]
GCS = Glasgow Coma Scale Score: Mild 14–15, Moderate 8–13, Severe < 8
ISS = Injury Severity Score: Mild 1–9, Moderate 10–25, Severe > 25
Fig. 1 The limitations of clinical and radiologic risk factors to screen
for BCVI
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This recognition led to the third important discovery
that has reduced the morbidity and mortality of these le-
sions, namely the identification of risk factors in blunt
trauma patients that warrant screening for BCVI prior to
the development of neurologic sequelae. By the late 1990’s
it was clear that there was an unrecognized epidemic of
BCVI [20]. In a meta-analysis done by Franz et al. [2] the
incidence range was 0.45–1.63 % in studies using 16-slice
or greater CTA. At the high end, this is 20 times higher
than the incidence in Davis’ study in 1990 [19] of 0.08 %.
Recognizing that most of these injuries are asymptom-
atic at the time of presentation, the groups in Denver
[11, 13, 21] and Memphis [1, 27–29] have, over the last
decade, elucidated an extensive list of clinical and
radiologic risk factors that warrant screening for BCVI.
Publication of practice management guidelines by the
WTA in 2009 [13] and EAST in 2010 [1] led to widespread
adoption of these screening criteria for BCVI. However,
despite subsequent broadening of the list of risk factors, it
has been recognized that at least 20–30 % of patients with
BCVI have none of the risk factors for screening outlined
in these organizational guidelines or other published re-
search [9, 14, 28].
In a study by Emmett et al. [28], most patients with sig-
nificant blunt trauma who warranted a head, C-spine, or
face CT to evaluate for potential injury underwent CTA of
the neck at the time of their initial trauma evaluation.
They found that this routine screening with CTA identi-
fied that 16 % of their patients with BCVI had none of the
conventional risk factors for screening. Further confirm-
ation of the lack of sensitivity of these widely used risk fac-
tors as screening criteria for BCVI has been published by
the group from Baltimore [9, 14]. Since 2004 they have
used a whole-body, multi-detector CT screening protocol
for blunt trauma patients clinically judged to be at high
risk for significant injury. In a study published in 2014
they found that 30 % of patients diagnosed with BCVI
using this technique had none of the radiologic or clinical
risk factors previously described for BCVI screening [14].
They concluded that the use of currently available risk fac-
tors to identify patients for screening would lead to missed
injury and stroke and that more liberalized screening for
BCVI during initial whole-body CT imaging based on
mechanism alone is warranted.
Based on our analysis of the literature, we had come to
a similar conclusion, even prior to publication of the Balti-
more study [14], and initiated a guideline for routine CTA
of the neck in patients undergoing CT of the C-spine and/
or CTA of the chest. This conclusion is now supported by
the finding in this study that 37 % of patients with BCVI
had none of these widely accepted risk factors.
Although 4-vessel digital subtraction angiography (DSA)
had long been considered the gold standard for the diag-
nosis of BCVI, most trauma surgeons do not currently
consider it to be the preferred method for screening pa-
tients for these injuries. The technique is invasive, expen-
sive, labor intensive, and continues to have a small but
measurable potential for complications, including stroke
[2, 29]. In addition, it may not be available outside of high
volume trauma centers and tertiary care hospitals [9, 14].
CTA, in comparison, is widely available, non-invasive,
rapid and cost effective and can be used to detect other in-
juries in the neck with a single imaging series. Although
earlier studies cautioned against use of CTA to identify
BCVI due to inadequate sensitivity, more recent data
from studies using multi-slice CT scanners have dem-
onstrated improved sensitivity allowing recommenda-
tion of its use for screening [29–31]. Moreover, based
on a recent survey, the use of CTA of the neck seems
to be widespread, with 93 % of 137 trauma surgeons
reporting CTA as their preferred method of imaging for
the diagnosis of BCVI [32].
There are several limitations to this study. The intent of
our screening protocol was to order a CTA of the neck in
any patient with sufficient mechanism or clinical suspicion
of injury to warrant imaging with CT of the C-spine and/
or CTA of the chest. However, only 19 % of post-protocol
blunt trauma patients underwent CTA of the neck. This
resulted from several factors. A significant number of low
mechanism and low risk patients were not felt to warrant
either CT of the C-spine or CTA of the chest and there-
fore did not undergo CTA of the neck. In addition, CTA
of the neck was not mandated in the absence of risk fac-
tors in those patients who had already undergone CT of
the C-spine and/or CTA of the chest, either prior to trans-
fer from an outside hospital or prior to consultation by
the trauma service. Nevertheless, institution of this guide-
line resulted in a 13-fold increase in the number of CTAs
of the neck obtained and a 5-fold increase in the percent-
age of patients in whom BCVI was identified. Given the
high risk of undiagnosed and untreated BCVI reported in
the literature, identification of these additional injuries by
a liberal screening guideline, and subsequent treatment,
almost certainly reduced the number of strokes in these
patients. Furthermore, although the incidence of BCVI
in all post-protocol patients was 1.1 %, the incidence
in the 19 % of patients who were screened with CTA
of the neck was 5.7 %. It is likely that more intensive
screening would yield an even higher incidence of
BCVI. For instance, approximately 40 % of our patients
were transferred from outside hospitals and most of
them had undergone CT imaging prior to transfer and
were therefore not mandated to undergo CTA of the
neck in the absence of risk factors. Based on our re-
sults we plan to recommend our clinical practice
guideline for BCVI screening to the 22 hospitals in our
system as well as other referring hospitals, and to im-
plement it within our emergency department physician
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group for patients seen prior to consultation by the
trauma service.
The optimal strategy for identification of BCVI con-
tinues to evolve. CTA now appears to be widely accepted
as the screening study of choice and given its low risk,
ubiquitous availability and reasonable cost in comparison
to angiography, it could even be considered the new gold
standard. Currently available screening guidelines fail to
identify more than a third of patients with BCVI and
should therefore no longer be considered adequate by
themselves for this purpose. In patients undergoing CT of
the C-spine and/or CTA of the chest, a dedicated CTA of
the neck can be obtained with no increase in radiation ex-
posure and minimal increase in the amount of contrast
administered. In addition, this technique of routine, simul-
taneous CTA of the neck in moderate and high risk blunt
trauma patients obviates the need for a return trip to the
CT scanner and additional radiation and contrast in pa-
tients who have risk factors identified on initial imaging.
This allows the earliest possible identification of these po-
tentially devastating injuries and initiation of simple, low
risk treatment (such as aspirin) which appears to reduce
the stroke rate to less than 1 % [5, 11, 21, 22]. Based on
the findings of this study we would recommend routine
CTA of the neck in all patients who have sustained a
mechanism of injury sufficient to warrant either a CT of
the C-spine or a CTA of the chest. This should minimize
the risk of missing occult BCVI in patients with these in-
juries who have none of the clinical or radiologic risk fac-
tors identified in currently available clinical screening
guidelines.
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